Clinical Trial: The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use Disorder

U.S., July 9 -- ClinicalTrials.gov registry received information related to the study (NCT07689981) titled 'The Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation in Individuals With Tiletamine Use Disorder' on July 01.

Brief Summary: Participants diagnosed with tiletamine use disorder will be assigned to active or sham taVNS for 5 days. Clinical outcomes ( e.g., behavioral paradigms measures and clinical scales ) and physiological markers (e.g., EEG and ECG) will be evaluated at baseline, post-treatment, and 3-month follow-ups to determine therapeutic efficacy and mechanisms of action.

Study Start Date: July 01

Study Type: INTERVENTIONAL

Condition: Tiletamine Use Disorder Substance Use Disorder (SUD) Drug Craving

Interventi...